Publications by authors named "Vivek P Shah"
Study Design: Retrospective Cohort.
Objective: To evaluate patient-reported outcome measures (PROM) and minimal clinically important difference (MCID) achievement outcomes between anterior cervical discectomy and fusion (ACDF) and cervical disk replacement (CDR) in the Workers' Compensation (WC) population.
Summary Of Background Data: No studies to our knowledge have compared PROMs and MCID attainment between ACDF and CDR among patients with WC insurance undergoing surgery in an outpatient ambulatory surgical center (ASC).
Objective: To determine the association between patient-reported depressive symptoms and patient satisfaction following minimally invasive lumbar decompression.
Methods: Primary, single-level/multilevel minimally invasive lumbar decompression was identified. Patient-reported outcome measures (PROMs) collected preoperatively/postoperatively included visual analog scale back/leg, Oswestry Disability Index, 9-Item Patient Health Questionnaire (PHQ-9), and 12-Item Short Form Mental Composite Score (SF-12 MCS).
Objective: To assess differences in postoperative patient-reported outcome measures (PROMs) and minimal clinically important difference (MCID) attainment following single-level anterior cervical discectomy and fusion based on predominant preoperative pain symptom.
Methods: Patients undergoing primary, single-level anterior cervical discectomy and fusion were identified. PROMs included visual analog scale (VAS) arm and neck, 12-item short-form physical component summary (SF-12 PCS), Patient-Reported Outcomes Measurement Information System Physical Function (PROMIS-PF), and Neck Disability Index, collected preoperatively and postoperatively.
Article Synopsis
- Researchers are investigating the use of recombinant human platelet-derived growth factor B homodimer (rhPDGF-BB) to enhance spinal fusion, given the limitations of autograft bone.
- The study, involving 80 female Fischer rats, tested four different implant types, including those with varying doses of rhPDGF-BB, and analyzed postoperative tissue response through imaging and cytokine quantification at multiple time points.
- Results indicated that rhPDGF-BB did not induce significant inflammatory responses or differences in tissue responses compared to the control, suggesting it may be a safe alternative for promoting spinal fusion.
Introduction: The relationship between surgeon experience and cervical fusion outcomes has yet to be assessed. We investigate perioperative characteristics, patient-reported outcomes (PROMs), and minimal clinically important difference (MCID) achievement after anterior cervical diskectomy and fusion (ACDF) by the volume of cases done throughout an orthopaedic spine surgeon's career.
Methods: ACDF procedures between 2005 and 2020 were identified.
There are a number of bone regeneration therapeutics available to aid spinal fusion; however, many are associated with pseudarthrosis, inflammation, and other complications. Mesenchymal stem cells for fusion has been promoted to mitigate these risks and achieve successful bony fusion. This article reviews the clinical studies available with use in spinal fusion.
View Article and Find Full Text PDF